Johan Spetz: Biodistribution of free I-125, I-131 and At-211 in rats
Cost-Effectiveness and Cost-Benefit Analysis N287E Spring 2006 Joanne Spetz 31 May 2006.
-
Upload
garry-thornton -
Category
Documents
-
view
215 -
download
0
Transcript of Cost-Effectiveness and Cost-Benefit Analysis N287E Spring 2006 Joanne Spetz 31 May 2006.
Cost-Effectiveness and Cost-Benefit Analysis
N287E Spring 2006Joanne Spetz31 May 2006
Optimal planning involves comparing marginal benefit and marginal cost
If a central health planner needs to pick the “right” level of production, how will she choose?
Social marginal benefit = Social marginal
cost
We can’t always see the “margin”
We can make choices with discrete projects
Benefit of project A >Benefit of project B
This is the purview of cost-effectiveness and cost-benefit analysis
Good CEA/CBA requires good measurement
How to measure benefits?
What are the benefits? Extended life Better quality of life
Reduced morbidity
Measurement options for benefits
Number of disease cases avertedNumber of years of life gained But what about differences in quality
of life?
Dollar value of saved life, reduced medical costs
Quality-adjusted life years
QALYs are a common way to weight for quality of life Each year of life is weighted by the
expected quality
Quality-adjusted life years
How do you determine QALYs? Clinical experts Experimental data Surveys
There is usually not measurement of individual preferences
Example of a QALY calculation
70-year-old man20 year life span10 years of perfect health10 years of 50% quality health(10 x 1 QALY/yr)+(10 x 0.5 QALY/yr) =
15QALYs
Some thoughts about QALYs
Social health can be the sum of population QALYsTrade-offs and comparisons can be made across people
What about creating monetary measures of benefits?
Option 1: Cost of illness Direct cost of medical care resources Indirect costs
Morbidity cost: wages lost due to inability to work and value of housekeeping
Mortality cost: present value of future earnings
Future earnings are “discounted” and summed
Problems with cost of illness
Men valued more than women (due to higher earnings)Ethnic groups valued differentlyChildren valued less than adultsWhat about quality of life?What is the value of non-market work?
What about creating monetary measures of benefits?
Option 2: Willingness to pay Choices that individuals make reveal
information about how they value life Information about value of life comes
from Surveys Data on consumer behavior
Problems with willingness to pay (and one benefit)
Surveys People can say anything Responses vary with income People misestimate risk
Consumer behavior Consumers might not have accurate risk
information Do you count the risk of injury?
WTP more directly addresses the concept of marginal utility
A few more thoughts on financial value of life
Willingness to pay usually values life more highly than discounted future earningsMost studies value life between $1 and $6 millionIn order to make policy decisions, a value of life must be made explicitly or implicitly
What is cost-benefit analysis?
Cost-benefit analysis compares costs and benefits, with benefits measured monetarilyNet benefit = (Bt-Ct)/(1+r)t If net benefit > 0 then do the project
Or, net benefit = (Bt/(1+r)t) (Ct/(1+r)t)
If net benefit > 1 then do the project
Measurements of costs
What is the viewpoint of the analysis Often “social perspective” Viewpoint of a particular agency The patient
What are the comparisons? Two or more treatment programs?
What categories of costs to include? How to handle capital expenditures How to discount for future costs
It is important to not double-count costs and benefits
Example: building a stadium “Jobs created”
But, we pay wages for the jobs! The payments for wages are a cost
“Property values will go up and businesses will get more income” The higher property values reflect the
increased income
To make a CBA-based decision…
Projects can be ranked by net benefitsInformal judgements can be made after ranking Income distribution can be considered Age distribution can be considered
What is cost-effectiveness analysis
CBA is disliked by many health professionalsCost-effectiveness analysis determines the cost of a certain Number of cases of disease prevented Number of QALYs obtained Other non-monetary measurement of
benefits
A classic example of CEA
What do we gain from the sixth stool guaiac? New England Journal of Medicine 1975 293: 226-228
Background on sixth stool guaiac
Six sequential tests for occult bloodIf any test is positive, a barium enema is done
The decision tree is:Test 1
Etc.
Test 2
Test 3
Test 4
neg
neg
neg
neg
pos
pos
pos
pos
enema
enema
enema
enema
What are the detection rates?
~72 people of 10,000 have colon cancer P(detection) = 91.66% P(false positive) = 36.51%
The first test detects 0.9166 x 72 = 65.9952 casesThe second test detects 99.3% of cases .993 = (.9166+.9166(1-.9166))
What about costs?
$4 for the initial test$1 for each additional test$100 for the barium enema
A detection grid for 10,000 people, Test 1
Cancer?
YES NO
POS 66 (91.66%)
309 (36.51%)
375 people
NEG 6 (1-.9166)
9619 9625 people
72 people 9928 people Go to Test
2
Test
resu
lt
Costs from first test
$4 x 10,000 = $40,000 for initial test$100 x 375 = $37,500 for barium enemasTotal = $77,500
A detection grid for Test 2 – 9625 people
Cancer?
YES NO
POS 5.5 299 304.50 people
NEG 0.5 9320 9320.5 people
6 people 9619 people Go to Test
3
Test
resu
lt
Cost from Test 2
$1 x 9625 for repeat test$100 x 304.5 for barium enemasTotal = $40,075
A detection grid for Test 3 – 9320.5 people
Cancer?
YES NO
POS .458 290 290.458 people
NEG .042 9030 9030.042 people
0.5 people
9320 people Go to Test
4
Test
resu
lt
Cost from Test 3
$1 x 9320.5 for repeat test$100 x 290.458 for barium enemasTotal = $38,366.30
How many cases are detected?
True positive False positive
# tests
% # cases % # cases
1 91.6667
65.9469
36.5079
309.1652
2 99.3056
71.4424
59.6876
505.4606
3 99.9421
71.9003
74.4048
630.0926
4 99.9952
71.9385
83.7491
709.2240
5 99.9996
71.9417
89.6819
759.4661
6 99.9999
71.9420
93.4489
791.3660
Cost analysis
# tests
# cases detected
Incre-ment
Total cost
Incre-ment
Marg cost/ marg gain
Average cost
1 65.9469
65.9469
$77,511 $77,511
$1,175 $1,175
2 71.4424
5.4956 $107,690
$30,179
$5,492 $1,507
3 71.9003
0.4580 $130,199
$22,509
$49,150 $1,810
4 71.9385
0.0382 $148,116
$17,917
$469,534 $2,059
5 71.9417
0.0032 $143,141
$15,024
$4,724,695
$2,268
6 71.9420
0.0003 $176,331
$13,190
$47,107,214
$2,451
Comparison
What if the barium enema was done for all patients?Total cost for 10,000 people would be $1,000,000Average cost per case detected = $13,900Marginal cost = $13,900
Sensitivity analysis
It is important to consider the assumptions made in the analysis Should some assumptions be
changed?
New technologies or information could affect conclusions
Sensitivity analysis in guaiac paper
Assume: Protocol detects only 60% of cases
per screening OR Population prevalence is lower,
11/10,000
Sensitivity analysis of costs
# tests Marg cost baseline
Marginal cost –
60% sensitive
Marginal cost –
low prevalence
1 $1,175 $1,743 $7,152
2 $5,492 $1,816 $35,505
3 $49,150 $3,353 $321,991
4 $469,534 $6,584 $3,078,108
5 $4,724,695
$13,696 $30,912,409
6 $47,107,214
$29,941 $325,476,150
What is an acceptable cost-effectiveness ratio?
There is no clear answer!Even if the ratio seems reasonable, we still might not be able to afford the cost We might not be able to invest today
for future gains
Most studies compare their cost-effectiveness ratios to those of well-accepted treatments/screenings
Can you apply this to nurse staffing?
Needleman & Buerhaus, Health Affairs 2006Rothberg, Abraham, et al., Medical Care 2005
Needleman & Buerhaus
Estimated costs of: More total nursing staff Substituting RNs for other staff
Benefits were cost savings in: Shorter length of stay Fewer adverse events Fewer deaths
Needleman & Buerhaus
Results Substituting RNs for other staff
produces net cost reduction Increasing total nursing hours
improves outcomes but also increases costs about 1.5% more
Rothberg et al.
Staffing comparison: 8:1 ratio vs. 4:1 ratio
Benefits: Cost savings from reduced LOS Lower patient mortality
Method: Statistical analysis with random variation in effects of staffing. Outcome = costs per life year saved
Rothberg et al.
Results: 1:8 was least expensive, highest mortality Mortality improved and costs rose and
nursing ratio became richer Incremental cost-effectiveness was $136,000
(95% CI $53,000-402,000) per life saved.
Sensitivity analysis: Sensitive to the effects of ratios on mortality Throughout the ranges tested, ICER <=
$449,000 per life saved.